#USA #New York #Class Action #Semler Scientific #Pomerantz Law

Investor Alert: Class Action Lawsuit Filed Against Semler Scientific

The Pomerantz Law Firm has alerted investors regarding a class action lawsuit against Semler Scientific Inc., traded under NASDAQ ticker SMLR. This legal action is designed to protect investors who have incurred losses as a result of potential securities fraud or other unlawful business practices by the company and certain of its executives.

Investors who bought Semler shares or were otherwise part of security transactions during the relevant class period are encouraged to join the lawsuit. If you believe you are eligible to be a lead plaintiff, you must act before October 28, 2025. Those interested can directly reach out to the firm’s attorney, Danielle Peyton, via email or phone. Including pertinent personal details such as mailing address and quantity of shares will expedite the process. Moreover, those claiming a financial stake during this period can obtain a copy of the complaint detailed at Pomerantz's official website.

The background of this lawsuit traces back to issues published in February 2025, when Semler filed its annual report. In the disclosure, the company warned about the risk of facing a civil lawsuit under the False Claims Act initiated by the U.S. Department of Justice (DOJ), concerning the QuantaFlo device used for treating peripheral artery disease. Reports indicate that Semler had received a civil investigative demand from the DOJ regarding reimbursement claims dating back to July 2017. Despite active negotiations, no settlement was achieved in February 2025, leading to a significant decrease in Semler’s stock price of $4.03, totaling a 9.4% drop on March 3, 2025.

The situation further deteriorated when on April 15, 2025, Semler announced a preliminary agreement with the DOJ for a $29.75 million settlement to address the claims. This news resulted in an additional decline in share value, by $3.40 or nearly 9.88%, closing at $31.00 on April 16, 2025.

Pomerantz Law Firm is recognized as a leader in handling class action litigation, especially concerning corporate and securities law. Since its foundation by Abraham L. Pomerantz over 85 years ago, the firm has fought tenaciously for investor rights, accumulating substantial financial recoveries for those affected by securities violations. The firm operates across several major cities globally, including New York, Chicago, London, and Tel Aviv, providing a robust support network for clients.

Investors are thus urged to evaluate their losses and consider participation in this class action to seek redress. The Pomerantz team assures that all inquiries and cases will be treated with utmost confidentiality, reflecting their long-established commitment to justice in securities law. For more details and further developments, staying tuned to Pomerantz Law Firm’s announcements is highly recommended.